{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:27:33Z","timestamp":1779114453975,"version":"3.51.4"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background and purpose<\/jats:title>\n                    <jats:p>Hemorrhagic transformation (HT) remains a critical complication of intravenous thrombolysis (IVT) in acute ischemic stroke (AIS), yet reliable pre-thrombolysis predictors are limited. We investigated whether pan-immune inflammation value (PIV) and neutrophil-to-albumin ratio (NAR), individually and in combination, are associated with HT and its subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this dual-center retrospective cohort study, 4,313 AIS patients treated with IVT were included. PIV and NAR were calculated from routine baseline blood tests. The primary outcome was any HT, with secondary outcomes including ECASS-classified subtypes: hemorrhagic infarction (HI1, HI2) and parenchymal hematoma (PH1, PH2). Associations were evaluated using multivariable logistic regression, restricted cubic spline (RCS) modeling, subgroup analyses, and receiver operating characteristic (ROC) curves.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Hemorrhagic transformation patients exhibited significantly higher PIV and NAR than non-HT patients, with the highest levels in PH1 and PH2. Multivariable analyses identified both PIV and NAR as independent predictors of overall HT, PH1, and PH2. Joint high PIV and NAR conferred a markedly increased risk (OR\u202f=\u202f6.63, 95% CI: 4.78\u20139.17). Subgroup analyses confirmed the consistency of associations across age, sex, baseline NIHSS, and comorbidities. RCS modeling demonstrated a logarithmic non-linear relationship between these inflammatory markers and HT risk (non-linearity\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05). ROC analysis showed that combining PIV and NAR substantially improved predictive accuracy (AUC\u202f=\u202f0.783, 95% CI: 0.761\u20130.804,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001) compared to individual markers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Elevated PIV and NAR are independently associated with increased risk of HT, particularly PH1 and PH2, after IVT in AIS patients. Integrating these biomarkers enhances predictive performance, supporting their potential utility in multidimensional risk stratification before thrombolysis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1724969","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:25:21Z","timestamp":1779110721000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pan-immune inflammation value and neutrophil-to-albumin ratio predict hemorrhagic transformation after intravenous thrombolysis in acute ischemic stroke: a dual-center cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhuang","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital with Nanjing Medical University","place":["Nanjing, Jiangsu, China"]},{"name":"The First School of Clinical Medicine, Nanjing Medical University","place":["Nanjing, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Geng","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital with Nanjing Medical University","place":["Nanjing, Jiangsu, China"]},{"name":"The First School of Clinical Medicine, Nanjing Medical University","place":["Nanjing, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hualin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital with Nanjing Medical University","place":["Nanjing, Jiangsu, China"]},{"name":"The First School of Clinical Medicine, Nanjing Medical University","place":["Nanjing, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Du","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Nanjing Medical University","place":["Nanjing, Jiangsu, China"]},{"name":"Department of Neurology, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kefan","family":"Yi","sequence":"additional","affiliation":[{"name":"Clinical Nutrition Department, Shanghai Deji Hospital, Qingdao University","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital with Nanjing Medical University","place":["Nanjing, Jiangsu, China"]},{"name":"The First School of Clinical Medicine, Nanjing Medical University","place":["Nanjing, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xufeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital with Nanjing Medical University","place":["Nanjing, Jiangsu, China"]},{"name":"The First School of Clinical Medicine, Nanjing Medical University","place":["Nanjing, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongsheng","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital with Nanjing Medical University","place":["Nanjing, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deqin","family":"Geng","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Nanjing Medical University","place":["Nanjing, Jiangsu, China"]},{"name":"Department of Neurology, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kezhong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital with Nanjing Medical University","place":["Nanjing, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1016\/S0140-6736(24)00642-1","article-title":"Stroke","volume":"403","author":"Hilkens","year":"2024","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/WCO.0000000000001004","article-title":"Intravenous thrombolysis for acute ischemic stroke: why not?","volume":"35","author":"Psychogios","year":"2022","journal-title":"Curr Opin Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e2309517","DOI":"10.1002\/advs.202309517","article-title":"Alleviating recombinant tissue plasminogen activator-induced hemorrhagic transformation in ischemic stroke via targeted delivery of a Ferroptosis inhibitor","volume":"11","author":"Geng","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e210020","DOI":"10.1212\/WNL.0000000000210020","article-title":"Patterns and clinical implications of hemorrhagic transformation after thrombolysis in acute ischemic stroke: results from the ENCHANTED study","volume":"103","author":"Wang","year":"2024","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e502","DOI":"10.1212\/WNL.0000000000207460","article-title":"Blood-brain barrier permeability and kinetics of inflammatory markers in acute stroke patients treated with Thrombectomy","volume":"101","author":"Bani-Sadr","year":"2023","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12974-022-02467-1","article-title":"Interleukin-6 and YKL-40 predicted recurrent stroke after ischemic stroke or TIA: analysis of 6 inflammation biomarkers in a prospective cohort study","volume":"19","author":"Li","year":"2022","journal-title":"J Neuroinflammation"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12974-016-0680-x","article-title":"Dynamic change of neutrophil to lymphocyte ratio and hemorrhagic transformation after thrombolysis in stroke","volume":"13","author":"Guo","year":"2016","journal-title":"J Neuroinflammation"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1161\/STROKEAHA.121.034366","article-title":"Prevalence and prognostic significance of malnutrition risk in patients with acute ischemic stroke: results from the third China National Stroke Registry","volume":"53","author":"Zhang","year":"2022","journal-title":"Stroke"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/j.clnu.2021.04.018","article-title":"Association between malnutrition and long-term mortality in older adults with ischemic stroke","volume":"40","author":"Yuan","year":"2021","journal-title":"Clin Nutr"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.numecd.2022.02.015","article-title":"A novel nutritional index and adverse outcomes in ischemic stroke: results from the third China national stroke registry","volume":"32","author":"Zhang","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13539-011-0024-8","article-title":"Sarcopenia in stroke\u2014facts and numbers on muscle loss accounting for disability after stroke","volume":"2","author":"Scherbakov","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1716041","DOI":"10.3389\/fimmu.2025.1716041","article-title":"Immune-mediated blood-brain barrier disruption after ischemic stroke: mechanisms and therapeutic targets","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1212\/01.wnl.0000330297.58334.dd","article-title":"The HAT score: a simple grading scale for predicting hemorrhage after thrombolysis","volume":"71","author":"Lou","year":"2008","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/ana.23546","article-title":"Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score","volume":"71","author":"Strbian","year":"2012","journal-title":"Ann Neurol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1212\/01.wnl.0000433418.06773.33","article-title":"Stroke prognostication using age and NIH stroke scale: SPAN-100","volume":"81","author":"Yufe","year":"2013","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1370516","DOI":"10.3389\/fimmu.2024.1370516","article-title":"Associations between pan-immune-inflammation value and abdominal aortic calcification: a cross-sectional study","volume":"15","author":"Jin","year":"2024","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e13872","DOI":"10.1111\/eci.13872","article-title":"Comparison of pan-immune-inflammation value with other inflammation markers of long-term survival after ST-segment elevation myocardial infarction","volume":"53","author":"Murat","year":"2023","journal-title":"Eur J Clin Investig"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e006136","DOI":"10.1136\/jitc-2022-006136","article-title":"Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumors","volume":"11","author":"Lemech","year":"2023","journal-title":"J Immunother Cancer"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1111\/jdv.18175","article-title":"Complete blood collection-based systemic inflammation biomarkers for patients with hidradenitis suppurativa","volume":"36","author":"Gambichler","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1326083","DOI":"10.3389\/fimmu.2024.1326083","article-title":"Pan-immune inflammation value as a prognostic biomarker for cancer patients treated with immune checkpoint inhibitors","volume":"15","author":"Kuang","year":"2024","journal-title":"Front Immunol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2174\/0115672026328594240614080241","article-title":"Neutrophil-to-albumin ratio as a prognostic factor in patients with acute ischemic stroke","volume":"21","author":"Bao","year":"2024","journal-title":"Curr Neurovasc Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/jso.25209","article-title":"NARCA: a novel prognostic scoring system using neutrophil-albumin ratio and Ca19-9 to predict overall survival in palliative pancreatic cancer","volume":"118","author":"Tingle","year":"2018","journal-title":"J Surg Oncol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"976216","DOI":"10.3389\/fnut.2022.976216","article-title":"Neutrophil-albumin ratio as a biomarker for postoperative complications and long-term prognosis in patients with colorectal cancer undergoing surgical treatment","volume":"9","author":"Xie","year":"2022","journal-title":"Front Nutr"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"27563","DOI":"10.1038\/s41598-024-78362-x","article-title":"Neutrophil-albumin ratio serves as a superior prognostic biomarker for traumatic brain injury","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1161\/STROKEAHA.120.031710","article-title":"Modifiable lifestyle factors and risk of stroke: a Mendelian randomization analysis","volume":"52","author":"Harshfield","year":"2021","journal-title":"Stroke"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.str.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"116445","DOI":"10.1016\/j.jns.2019.116445","article-title":"Neutrophil to lymphocyte ratio predicts poor outcomes after acute ischemic stroke: a cohort study and systematic review","volume":"406","author":"Wang","year":"2019","journal-title":"J Neurol Sci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e70133","DOI":"10.1111\/cns.70133","article-title":"Integrating neutrophil-to-albumin ratio and triglycerides: a novel Indicator for predicting spontaneous hemorrhagic transformation in acute ischemic stroke patients","volume":"30","author":"Bao","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/s0140-6736(98)08020-9","article-title":"Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian acute stroke study investigators","volume":"352","author":"Hacke","year":"1998","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1161\/01.str.32.2.438","article-title":"Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian acute stroke study (ECASS II)","volume":"32","author":"Larrue","year":"2001","journal-title":"Stroke"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/jama.1995.03530130023023","article-title":"Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European cooperative acute stroke study (ECASS)","volume":"274","author":"Hacke","year":"1995","journal-title":"JAMA"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e2120745","DOI":"10.1001\/jamanetworkopen.2021.20745","article-title":"Clinical characteristics, management, and in-hospital outcomes in patients with stroke or transient ischemic attack in China","volume":"4","author":"Gu","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/bc.bc_73_22","article-title":"Risk factors for multiple recurrent ischemic strokes","volume":"9","author":"Uzuner","year":"2023","journal-title":"Brain Circ"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/00001648-199209000-00012","article-title":"Confidence interval estimation of interaction","volume":"3","author":"Hosmer","year":"1992","journal-title":"Epidemiology"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1161\/STROKEAHA.119.028287","article-title":"The incidence and associated factors of early neurological deterioration after thrombolysis: results from SITS registry","volume":"51","author":"Yu","year":"2020","journal-title":"Stroke"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.jtha.2024.01.002","article-title":"Hemorrhagic transformation after acute ischemic stroke thrombolysis treatment: navigating the landscape of hemostasis genetic risk factors","volume":"22","author":"Bagoly","year":"2024","journal-title":"J Thromb Haemost"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"847648","DOI":"10.3389\/fnagi.2022.847648","article-title":"Treatment and outcomes of thrombolysis related hemorrhagic transformation: a multi-center study in China","volume":"14","author":"Liu","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/jnis-2024-021725","article-title":"Hemorrhagic transformation in acute ischemic stroke: hemorrhagic subtypes and symptomatic intracranial hemorrhage","volume":"17","author":"Luff","year":"2025","journal-title":"J Neurointerv Surg"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"5871","DOI":"10.1016\/j.cell.2024.09.018","article-title":"Pioneering discovery and therapeutics at the brain-vascular-immune interface","volume":"187","author":"Akassoglou","year":"2024","journal-title":"Cell"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12975-014-0384-4","article-title":"An update on inflammation in the acute phase of intracerebral hemorrhage","volume":"6","author":"Chen","year":"2015","journal-title":"Transl Stroke Res"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"113645","DOI":"10.1016\/j.expneurol.2021.113645","article-title":"Lipoxin A4 regulates microglial M1\/M2 polarization after cerebral ischemia-reperfusion injury via the notch signaling pathway","volume":"339","author":"Li","year":"2021","journal-title":"Exp Neurol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1172\/JCI135530","article-title":"Immune responses to stroke: mechanisms, modulation, and therapeutic potential","volume":"130","author":"Iadecola","year":"2020","journal-title":"J Clin Invest"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nrn1765","article-title":"Central nervous system injury-induced immune deficiency syndrome","volume":"6","author":"Meisel","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1161\/01.STR.0000251441.89665.bc","article-title":"Stroke-induced immunodepression: experimental evidence and clinical relevance","volume":"38","author":"Dirnagl","year":"2007","journal-title":"Stroke"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s12975-016-0480-8","article-title":"Intraventricular hemorrhage: the role of blood components in secondary injury and hydrocephalus","volume":"7","author":"Garton","year":"2016","journal-title":"Transl Stroke Res"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1534018","DOI":"10.3389\/fendo.2025.1534018","article-title":"Pan-immune-inflammation value and its association with all-cause and cause-specific mortality in the general population: a nationwide cohort study","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Endocrinol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1465.e11","DOI":"10.1016\/j.amjmed.2017.07.020","article-title":"Low albumin levels are associated with mortality risk in hospitalized patients","volume":"130","author":"Akirov","year":"2017","journal-title":"Am J Med"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e039860","DOI":"10.1136\/bmjopen-2020-039860","article-title":"Association between neutrophil-to-albumin ratio and mortality in patients with cardiogenic shock: a retrospective cohort study","volume":"10","author":"Peng","year":"2020","journal-title":"BMJ Open"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"11832","DOI":"10.26355\/eurrev_202312_34781","article-title":"Neutrophil-to-albumin ratio: a promising tool for CAD assessment in non-ST elevation AMI","volume":"27","author":"Karasu","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12883-023-03433-x","article-title":"Association between neutrophil-to-albumin ratio and long-term mortality of aneurysmal subarachnoid hemorrhage","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Neurol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"21976","DOI":"10.1038\/s41598-025-08130-y","article-title":"Neutrophil to albumin ratio predicts cardiovascular and all cause mortality in CVD patients with abnormal glucose metabolism","volume":"15","author":"Li","year":"2025","journal-title":"Sci Rep"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"8273","DOI":"10.3390\/ijms25158273","article-title":"Inflammation, oxidative stress, and endothelial dysfunction in the pathogenesis of vascular damage: unraveling novel cardiovascular risk factors in Fabry disease","volume":"25","author":"Faro","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1098725","DOI":"10.3389\/fimmu.2022.1098725","article-title":"Role of inflammation, immunity, and oxidative stress in hypertension: new insights and potential therapeutic targets","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.febslet.2008.04.057","article-title":"The antioxidant properties of serum albumin","volume":"582","author":"Roche","year":"2008","journal-title":"FEBS Lett"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1087815","DOI":"10.3389\/fimmu.2023.1087815","article-title":"Immune regulation based on sex differences in ischemic stroke pathology","volume":"14","author":"Niu","year":"2023","journal-title":"Front Immunol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"e70523","DOI":"10.1111\/cns.70523","article-title":"Targeting PD-L1 for ischemic stroke recovery: age-dependent modulation of immune and BBB pathways","volume":"31","author":"Hang","year":"2025","journal-title":"CNS Neurosci Ther"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"841484","DOI":"10.3389\/fneur.2022.841484","article-title":"The smoking paradox in stroke patients under reperfusion treatment is associated with endothelial dysfunction","volume":"13","author":"Iglesias-Rey","year":"2022","journal-title":"Front Neurol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3390\/life14030311","article-title":"Influence of alcohol on intracerebral hemorrhage: from oxidative stress to glial cell activation","volume":"14","author":"Thangameeran","year":"2024","journal-title":"Life (Basel)"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12883-023-03222-6","article-title":"Elevated NT-proBNP predicts unfavorable outcomes in patients with acute ischemic stroke after thrombolytic therapy","volume":"23","author":"Zhu","year":"2023","journal-title":"BMC Neurol"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1724969\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:25:22Z","timestamp":1779110722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1724969\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":60,"alternative-id":["10.3389\/fnut.2026.1724969"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1724969","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"article-number":"1724969"}}